关注今日：1 | 主题：408771
微信扫一扫
扫一扫，下载丁香园 App
即送15丁当
【资讯翻译】纳米药物使干眼症麻烦更少
页码直达：
【认 领 须 知】1、认领翻译的战友请跟帖注明“认领本文翻译，48小时内未完成，请其他战友认领！”2、请根据自己专业背景选择认领，如使用翻译软件翻译，被发现者扣分1-2分3、经常认领而不能及时提供优质稿件者将被列入黑名单，取消认领资格，请大家注意！4、翻译时请参照版规：
5、在首位认领战友未超过规定时间的其他任何认领属违规认领，将不会给予丁当或加分！6、翻译完成后加分（或丁当）的时限为三日，请耐心等待，若超过时限未加者可进行申诉：7、本文题目仅供译者参考，篇幅较长者可申请适当延时8、翻译前请查一下有无重复帖9、为保证翻译质量，每人每天最多只能认领两篇原文链接：/articles/283668.phpNano-drug for dry eyes brings relief with less troubleA team of researchers hopes that in the not too distant future, millions of people who suffer from dry eyes will not have to apply eye drops three times a day. They are developing eye drops that use drug-infused nanoparticles - and feel no different to plain water - that will only have to be applied once a week.Over 6% of people in the US suffer from , a result of an imbalance between tear production and tear drainage. It is more common in the over-50s and can eventually cause eye damage.Drugs to treat the condition exist, but they have to be applied via drops three times a day because the eye is very efficient at washing them away.Drug-infused nanoparticles stick to the surface of the eyeNow a team from the University of Waterloo, ON, Canada, has developed a solution that only needs to be applied once a week. The solution contains drug-infused nanoparticles that stick to the surface of the eye, prolonging the time that the symptom-relieving drug stays in place.Over 6% of people in the US suffer from dry eye syndrome, a result of an imbalance between tear production and tear drainage.In a study reported in the journal Nano Research, they describe how they treated mice with dry eyes with nanoparticles infused with the drug Cyclosporine A (CycA) and found they &sustained the release for up to 5 days at a clinically relevant dose.&They then ran another series of tests where they only gave the mice a weekly dose of the drug-infused nanoparticles. Signs of
were eliminated and the surface of the animals' eyes &completely recovered,& they note.The same once a week dosage also produced no signs of physical irritation or inflammation when tested in rabbits' eyes.The nanoparticles - which are about 1,000 times smaller than the width of a human hair - stick to the surface of the eyeball and use only 5% of the amount of drug normally required. The body eventually absorbs them harmlessly.Challenge was finding way to make the nanoparticles stick to the eye surfaceA challenge in the study was to find a way to make the nanoparticles stick to the eye surface. The team achieved this &by surface functionalizing the nanoparticles with phenylboronic acid,& and forming the nanoparticles &from self-assembly of block copolymers composed of poly(d, l-lactide) and Dextran.&Lead author Shengyaen (Sandy) Liu, a PhD student at Waterloo's Faculty of Engineering, explains:&I knew that if we focused on infusing biocompatible nanoparticles with Cyclosporine A, the drug in the eye drops, and make them stick to the eyeball without irritation for longer periods of time, it would also save patients time and reduce the possibility of toxic exposure due to excessive use of eye drops.&He says, &You can't tell the difference between these nanoparticle eye drops and water. There's no irritation to the eye.&The team is now working on setting up clinical trials to test the nanoparticle eye drops and foresees them being available in drugstores in the next 5 years.The Natural Sciences and Engineering Research Council of Canada and 20/20: Ophthalmic Materials Network funded the study.In August 2014, Medical News Today reported how another team - inspired by lubricants found in nature - is developing a . One possible application is to make contact lenses more comfortable.
不知道邀请谁？试试他们
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
认领本文翻译，48小时内未完成，请其他战友认领！
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园准中级站友
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
文献标题：Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentally induced dry eye syndrome杂志名称：Nano Research, DOI:10.1038/bjc.,PMID：暂无第一页截图：
(3244.74k)
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
认领本文翻译
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
liuygi edited on
初译Nano-drug for dry eyes brings relief with less trouble纳米药物可缓解眼干症状1.A team of researchers hopes that in the not too distant future, millions of people who suffer from dry eyes will not have to apply eye drops three times a day. They are developing eye drops that use drug-infused nanoparticles - and feel no different to plain water - that will only have to be applied once a week.某研究团队希望在不久的将来，使数以百万的遭受眼干痛苦的患者将不必再一天三次的滴加眼药。他们正在研制一种纳米颗粒制剂，应用这种药物时的感觉与应用普通滴眼液的感觉没什么不同，并且这种药物只需一周应用一次。2.Over 6% of people in the US suffer from dry eye syndrome, a result of an imbalance between tear production and tear drainage. It is more common in the over-50s and can eventually cause eye damage.在美国有超过6% 的人遭受眼干综合征的折磨，造成这种结果的一个原因就是泪液的分泌与流出的失衡。这种症状在50岁以上的人身上更为常见，并且最终可能会造成眼损伤。3.Drugs to treat the condition exist, but they have to be applied via drops three times a day because the eye is very efficient at washing them away.虽然治疗这种疾病的药物并不缺乏，但是他们必须被一天三次的滴加。因为眼睛会很快的将药物冲刷掉。Drug-infused nanoparticles stick to the surface of the eye添加药物的纳米颗粒制剂能强烈的粘附在眼睛的表面4.Now a team from the University of Waterloo, ON, Canada, has developed a solution that only needs to be applied once a week. The solution contains drug-infused nanoparticles that stick to the surface of the eye, prolonging the time that the symptom-relieving drug stays in place.如今来自加拿大安大略省的滑铁卢大学的一个研究团队，已经发明出一种只需一周应用一次的有效方法。这种方法应用了一种粘附在眼球表面的纳米药物颗粒，这种药物能长期停留在用药部位以缓解眼干症状。5.Over 6% of people in the US suffer from dry eye syndrome, a result of an imbalance between tear production and tear drainage.在美国有超过6% 的人遭受眼干综合征的折磨，造成这种结果的一个原因就是泪液的分泌与流出的失衡。6.In a study reported in the journal Nano Research, they describe how they treated mice with dry eyes with nanoparticles infused with the drug Cyclosporine A (CycA) and found they &sustained the release for up to 5 days at a clinically relevant dose.&《纳米研究》这本杂志对这个研究做了相关报道，并描述了这个团队是如何将添加了环孢菌素A的纳米颗粒应用于患有眼干症的小鼠眼部的。他们发现“应用临床所用的计量，这种药物的有效释放期达到了5天。”7.They then ran another series of tests where they only gave the mice a weekly dose of the drug—infused nanoparticles. Signs of inflammation were eliminated and the surface of the animals' eyes &completely recovered,& they note.他们还进行了其他的一系列实验。在这些实验中他们一周给小鼠应用一次这种添加药物的纳米颗粒。炎症迹象逐渐消除，他们还提到：“小鼠的眼干症状得到了治愈”8.The same once a week dosage also produced no signs of physical irritation or inflammation when tested in rabbits' eyes.当以相同的剂量一周一次的应用于兔子眼部时，过敏和炎症的症状也得到了消除。9.The nanoparticles - which are about 1,000 times smaller than the width of a human hair - stick to the surface of the eyeball and use only 5% of the amount of drug normally required. The body eventually absorbs them harmlessly.这种比人的头发直径小大约1000倍的纳米颗粒可粘附在眼球的表面，并且仅需要正常用药量的5%。机体最终会无害地吸收掉这些颗粒。Challenge was finding way to make the nanoparticles stick to the eye surface挑战就是找到将纳米颗粒粘附在眼表面的方法10.A challenge in the study was to find a way to make the nanoparticles stick to the eye surface. The team achieved this &by surface functionalizing the nanoparticles with phenylboronic acid,& and forming the nanoparticles &from self-assembly of block copolymers composed of poly(d, l-lactide) and Dextran.&研究中的一项挑战就是找到一种纳米颗粒粘附在眼部的方法。但是团队通过应用“苯磺酸与纳米材料结合从而使其活化的方法”克服了这个困难，它能形成一种由极性物质和右旋糖酐组成的嵌段共聚物从而自行组装成的纳米材料。11.Lead author Shengyaen (Sandy) Liu, a PhD student at Waterloo's Faculty of Engineering, explains:&I knew that if we focused on infusing biocompatible nanoparticles with Cyclosporine A, the drug in the eye drops, and make them stick to the eyeball without irritation for longer periods of time, it would also save patients time and reduce the possibility of toxic exposure due to excessive use of eye drops.&这篇论文的带头作者—滑铁卢大学工程系博士生Shengyaen (Sandy) Liu解释道：“如果我们将研究重点放在将环孢菌素A添加在与生物相适应的纳米材料上，从而作为滴眼剂的药物，进而使他们毫无刺激的长时间粘附于眼球上，这也会节约患者的时间以及降低患者因多次使用滴眼液从而增加的感染风险。”12.He says, &You can't tell the difference between these nanoparticle eye drops and water. There's no irritation to the eye.&The team is now working on setting up clinical trials to test the nanoparticle eye drops and foresees them being available in drugstores in the next 5 years.他说：“你根本无法区别纳米滴眼液与普通滴眼液的区别。他们对眼睛毫无刺激。”如今这个团队正致力于这种纳米滴眼液的临床试验，并且预测5年后将出现在药房的专柜。13.The Natural Sciences and Engineering Research Council of Canada and 20/20: Ophthalmic Materials Network funded the study.In August 2014, Medical News Today reported how another team - inspired by lubricants found in nature - is developing a new material that delivers long-lasting lubrication. One possible application is to make contact lenses more comfortable.加拿大自然科学与工程研究委员会以及眼科材料网络资助了这项研究。2014年8月今日医学新闻报道了另一个团队是如何从自然界的润滑油上发现灵感的，这种润滑油有望能逐渐发展成一种新的有持久润滑功能的材料。一个可能的应用就是制造出更加舒适的隐形眼镜。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
rightherewaiting edited on
编译 字数统计：1089纳米药物可缓解眼干症状某研究团队希望在不久的将来，使数以百万的遭受眼干痛苦的患者将不必再一天三次的滴加眼药。他们正在研制一种纳米颗粒制剂，应用这种药物时的感觉与应用普通滴眼液的感觉没什么不同，并且这种药物只需一周应用一次。在美国有超过6% 的人遭受眼干综合征的折磨，造成这种结果的一个原因就是泪液的分泌与排出的失衡。这种症状在50岁以上的人身上更为常见，并且最终可能会造成眼损伤。虽然治疗这种疾病的药物并不缺乏，但是他们必须被一天三次的滴加。因为眼睛会很快的将药物冲刷掉。添加药物的纳米颗粒制剂能强烈的粘附在眼睛的表面如今来自加拿大安大略省的滑铁卢大学的一个研究团队，已经发明出一种只需一周应用一次的有效方法。这种方法应用了一种纳米药物颗粒，这种药物能长期停留在用药部位以缓解眼干症状。在美国有超过6% 的人遭受眼干综合征的折磨，造成这种结果的一个原因就是泪液的分泌与排出的失衡。《纳米研究》这本杂志对这个研究做了相关报道，并描述了这个团队是如何将添加了环孢菌素A的纳米颗粒应用于患有眼干症状的小鼠眼部的方法。他们发现“应用临床所用的计量，这种药物的有效释放期达到了5天。”他们还进行了其他的一系列实验。在这些实验中他们一周给小鼠应用一次这种添加药物的纳米颗粒。炎症迹象逐渐消除，他们还提到：“小鼠的眼干症状得到了治愈”当以相同的剂量一周一次的应用于兔子眼部时，过敏和炎症的症状也得到了消除。这种比人的头发直径小大约1000倍的纳米颗粒可粘附在眼球的表面，并且仅需要正常用药量的5%。机体最终会无害地吸收掉这些颗粒。挑战就是找到将纳米颗粒粘附在眼表面的方法本研究难就难在找到一种将纳米颗粒粘附在眼球表面的方法。该团队通过用“苯硼酸使纳米颗粒表面功能化以及通过由聚（d,l-丙交酯）和右旋糖酐组成的嵌段聚合物的自装配生成纳米颗粒，达到了这个目的。这篇论文的带头作者—滑铁卢大学工程系博士生Shengyaen (Sandy) Liu解释道：“如果我们将研究重点放在将环孢菌素A添加在与生物相适应的纳米材料上，从而作为滴眼剂的药物，进而使他们毫无刺激的长时间粘附于眼球上，这也会节约患者的时间以及降低患者因多次使用滴眼液从而增加的感染风险。”他说：“你根本无法区别纳米滴眼液与普通滴眼液的区别。他们对眼睛毫无刺激。”如今这个团队正致力于这种纳米滴眼液的临床试验，并且预测5年后将出现在药房的专柜。加拿大自然科学与工程研究委员会以及眼科材料网络资助了这项研究2014年8月今日医学新闻报道了另一个团队是如何从自然界的润滑油上发现灵感的，这种润滑油有望能逐渐发展成一种新的有持久润滑功能的材料。一个可能的应用就是制造出更加舒适的隐形眼镜。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
rightherewaiting edited on
丁香园中级站友
互相学习，一些问题前来讨论：1.Nano-drug for dry eyes brings relief with less trouble纳米药物可缓解眼干症状不论是版主提供的“纳米药物使干眼症麻烦减少”，还是译者的“纳米药物可缓解眼干症状”，都只翻译了一部分。个人修改：纳米药物在缓解干眼症时带来的麻烦较少。欢迎更好的译法。2.millions of people who suffer from dry eyes数以千万的遭受眼干痛苦的患者million：百万（其实都是开区间……尽量准确些总没有错）3.a team from the University of Waterloo, ON, Canada来自加拿大滑铁卢大学的一个研究团队ON漏译：安大略省，简称“安省”，ON是其邮编缩写。 4.The solution contains drug-infused nanoparticles that stick to the surface of the eye, prolonging the time that the symptom-relieving drug stays in place.这种方法应用了一种纳米药物颗粒，这种药物能长期停留在用药部位以缓解眼干症状。stick to the surface of the eye漏译：黏贴在眼球的表面5.In a study reported in the journal Nano Research, they describe how they treated mice with dry eyes with nanoparticles infused with the drug Cyclosporine A (CycA) and found they &sustained the release for up to 5 days at a clinically relevant dose.&《纳米研究》这本杂志对这个研究做了相关报道，并描述了这个团队是如何将添加了环孢菌素A的纳米颗粒应用于小鼠眼部的方法。他们发现“应用临床所用的计量，这种药物的有效释放期达到了5天。”with dry eyes 漏译：患干眼症的小鼠同时译文“描述了这个团队是如何将添加了环孢菌素A的纳米颗粒应用于小鼠眼部的方法”是个病句：‘是如何’与“的方法”只能2选1。5.The same once a week dosage also produced no signs of physical irritation or inflammation when tested in rabbits' eyes.当以相同的剂量一周一次的应用于兔子眼部时，过敏和炎症的症状也得到了消除。physical irritation：过敏？物理刺激？此处期待其他站友解惑6.The nanoparticles - which are about 1,000 times smaller than the width of a human hair - stick to the surface of the eyeball and use only 5% of the amount of drug normally required. The body eventually absorbs them harmlessly.这种纳米材料比人类头发直径的千分之一还要小，它能有效地粘附在眼球的表面，并且只需应用药物常用量的5%。机体会不受任何伤害的吸收他们。about漏译：大约；“有效”：原文无此义，建议去掉；eventually漏译：最终。顺便润色下：这种比人的头发直径小大约1000倍的纳米颗粒可粘附在眼球的表面，并且仅需要正常用药量的5%。机体最终会无害地吸收掉这些颗粒。7.Challenge was finding way to make the nanoparticles stick to the eye surface最大的挑战就是找到将纳米颗粒粘附在眼表面的方法’最大‘二字从何而来？去掉8.reduce the possibility of toxic exposure due to excessive use of eye drops.&降低患者因多次使用滴眼液从而增加的感染风险。”toxic——毒性
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
你妹呀 edited on
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
10.A challenge in the study was to find a way to make the nanoparticles stick to the eye surface. The team achieved this &by surface functionalizing the nanoparticles with phenylboronic acid,& and forming the nanoparticles &from self-assembly of block copolymers composed of poly(d, l-lactide) and Dextran.&研究中的一项挑战就是找到一种纳米颗粒粘附在眼部的方法。但是团队通过应用“苯磺酸与纳米材料结合从而使其活化的方法”克服了这个困难，它能形成一种由极性物质和右旋糖酐组成的嵌段共聚物从而自行组装成的纳米材料。phenylboronic，苯硼酸，不是苯磺酸，常用于交联反应；poly(d, l-lactide)，聚（d,l-丙交酯）,亦即聚乳酸，一种生物可降解材料。本研究难就难在找到一种将纳米颗粒粘附在眼球表面的方法。该团队通过用“苯硼酸使纳米颗粒表面功能化以及通过由聚（d,l-丙交酯）和右旋糖酐组成的嵌段聚合物的自装配生成纳米颗粒，达到了这个目的。不过从逻辑上说，自装配在前，功能化在后。原始论文其实就是这么说的。“The nanoparticles were formed from self-assembly of block copolymers composed of poly(D, L-lactide) and Dextran. The enhanced mucoadhesion properties were achieved by surface functionalizing the nanoparticles with phenylboronic acid.”本文这么说也许是强调研究的亮点。&I knew that if we focused on infusing biocompatible nanoparticles with Cyclosporine A, the drug in the eye drops, and make them stick to the eyeball without irritation for longer periods of time, it would also save patients time and reduce the possibility of toxic exposure due to excessive use of eye drops.&这篇论文的带头作者—滑铁卢大学工程系博士生Shengyaen (Sandy) Liu解释道：“如果我们将研究重点放在将环孢菌素A添加在与生物相适应的纳米材料上，从而作为滴眼剂的药物，进而使他们毫无刺激的长时间粘附于眼球上，这也会节约患者的时间以及降低患者因多次使用滴眼液从而增加的感染风险。”infusing 还是译“融合”好，不宜译“添加”。因为原始论文是用“In vitro Cyclosporine A encapsulation and release”来表述的。当然infusing也并不恰当，但这是本文用通俗的语言来代替“胶囊化”。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
2.an imbalance between tear production and tear drainage
泪液的生产与流出的失衡
改为“ 分泌与排出的失衡”
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园版主
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园助理版主
译文专业、流畅。学习中……参与校对修改，若干小商榷，个人意见，仅供参考。 保留原译文原序号标题Nano-drug for dry eyes brings relief with less trouble建议译文：纳米药物可缓解干眼症症状说明：干眼症是一个眼科专有名词1.A team of researchers hopes that in the nottoo distant future, millions of people who suffer from dry eyes will not haveto apply eye drops three times a day. They are developing eye drops that usedrug-infused nanoparticles - and feel no different to plain water - that willonly have to be applied once a week.某研究团队希望在不久的将来，使数以千万的遭受眼干痛苦的患者将不必再一天三次的滴加眼药。他们正在研制一种纳米颗粒制剂，应用这种药物时的感觉与应用普通滴眼液的感觉没什么不同，并且这种药物只需一周应用一次。建议译文：某研究团队希望在不太久的将来，使数以百万的遭受干眼症痛苦的患者将不必再一天三次药。他们正在研发一种在应用时感觉与普通水无异的纳米颗粒制剂滴眼液，一周只需用一次。说明：plain water 淡水、平常水、普通水，plain water不是“普通滴眼液”。用于干眼症的滴眼液已有多种面世，不是普通水，各有千秋，大有讲究。并非就是plain water2.Over 6% of people in the US suffer from dry eye syndrome, aresult of an imbalance between tear production and tear drainage. It is morecommon in the over-50s and can eventually cause eye damage.在美国有超过6% 的人遭受眼干综合征的折磨，造成这种结果的一个原因就是泪液的生产与流出的失衡。这种症状在50岁以上的人身上更为常见，并且最终可能会造成眼损伤。建议译文：在美国有超过6% 的人患干眼综合征，这是泪液产生与引流失衡的结果，在50岁以上更为常见，且最终可造成眼损伤。3.Drugs to treat the condition exist, butthey have to be applied via drops three times a day because the eye is veryefficient at washing them away.虽然治疗这种疾病的药物并不缺乏，但是他们必须被一天三次的滴加。因为眼睛会很快的将药物冲刷掉。建议译文：虽然已有治疗这种疾病的药物，但须一天三次滴眼，因为眼会高效地将药物冲洗走。Drug-infused nanoparticles stick to the surface of the eye添加药物的纳米颗粒制剂能强烈的粘附在眼睛的表面建议译文：添加药物的纳米颗粒制剂可粘附于眼表面4.Now a team from the University of Waterloo,ON, Canada, has developed a solution that only needs to be applied once a week.The solution contains drug-infused nanoparticles that stick to the surface ofthe eye, prolonging the time that the symptom-relieving drug stays in place.如今来自加拿大滑铁卢大学的一个研究团队，已经发明出一种只需一周应用一次的有效方法。这种方法应用了一种纳米药物颗粒，这种药物能长期停留在用药部位以缓解眼干症状。建议译文：如今加拿大滑铁卢大学的一个研究团队，已研发出一种只需一周应用一次的溶液。该溶液含纳米药物颗粒，可粘附于眼表面，延长缓解症状的药物停留在合适部位时间。5.Over 6% of people in the US suffer from dry eye syndrome, aresult of an imbalance between tear production and tear drainage.在美国有超过6% 的人遭受眼干综合征的折磨，造成这种结果的一个原因就是泪液的生产与流出的失衡。建议译文：在美国有超过6% 的人患干眼综合征，这是泪液产生与引流失衡的结果。6.In a study reported in the journal NanoResearch, they describe how they treated mice with dry eyes with nanoparticlesinfused with the drug Cyclosporine A (CycA) and found they &sustained therelease for up to 5 days at a clinically relevant dose.&《纳米研究》这本杂志对这个研究做了相关报道，并描述了这个团队是如何将添加了环孢菌素A的纳米颗粒应用于小鼠眼部的方法。他们发现“应用临床所用的计量，这种药物的有效释放期达到了5天。”建议译文：刊于《纳米研究》杂志的这个研究描述了这个团队是如何以环孢菌素A的纳米颗粒治疗干眼症小鼠，发现“维持临床相关剂量药物释放达5天。”7.They then ran another series of tests where they gavethe mice a weekly dose of the drug—infused nanoparticles. Signs of inflammationwere eliminated and the surface of the animals' eyes &completelyrecovered,& they note.他们还进行了其他的一系列实验。在这些实验中他们一周给小鼠应用一次这种添加药物的纳米颗粒。炎症迹象逐渐消除，他们还提到：“小鼠的眼干症状得到了治愈”建议译文：他们随后进行了另一系列测试，仅给小鼠一周一次应用这种浸泡药物的纳米颗粒。他们注意到炎症征象消除，动物眼表面“完全康复”说明：[1]
only 在此有意义，不应完全忽略[2] 炎症迹象逐渐消除，“逐渐”为随意添加[3]
thesurface of the animals' eyes &completely recovered,& 译为“小鼠的眼干症状得到了治愈”与原文距离与变动过大8.The same once a week dosage also producedno signs of physical irritation or inflammation when tested in rabbits'eyes.当以相同的剂量一周一次的应用于兔子眼部时，过敏和炎症的症状也得到了消除。建议译文：以相同的一周一次剂量在兔子眼部测试时，亦未见物理刺激和炎症的征象。说明：本句原译文理解有误。[1] 原译文”当以……于兔子眼部时，过敏和炎症的症状也得到了消除。” 是沿用上一句的思路，认为是在应用干眼症疾病动物模型作实验，才有“（原先存在的）……症状也得到了消除”的译法。其实，本句并未说是用已有干眼症的动物模型作实验。相反，这里是在进行药物安全性方面的一些试验：用的是正常动物，测试药物对眼有无刺激作用[2]
physical irritation
irritation刺激，不是“过敏”[3]“相同的剂量”，这表述也不完全精确，兔子和小鼠不可能用完全“相同的剂量”，我的理解，这里The same once a week dosage 指的主要是同样一周一剂的用药方案，具体剂量如何没说。也可能滴眼液浓度相同，滴眼的滴眼液滴数则可能主要依照测试药物对眼刺激试验的规程10.A challenge in the study was to find a wayto make the nanoparticles stick to the eye surface. The team achieved this&by surface functionalizing the nanoparticles with phenylboronicacid,& and forming the nanoparticles &from self-assembly of blockcopolymers composed of poly(d, l-lactide) and Dextran.&研究中的一项挑战就是找到一种纳米颗粒粘附在眼部的方法。但是团队通过应用“苯磺酸与纳米材料结合从而使其活化的方法”克服了这个困难，它能形成一种由极性物质和右旋糖酐组成的嵌段共聚物从而自行组装成的纳米材料。建议译文：该研究中的一项挑战就是要找到一种使纳米颗粒粘附在眼部的方法。这团队通过 “以苯硼酸活化纳米颗粒表面”实现了这一点，并形成一种由poly(d, l-lactide)和右旋糖酐组成的嵌段共聚物自组装成的纳米颗粒。11.Lead author Shengyaen (Sandy) Liu, a PhDstudent at Waterloo's Faculty of Engineering, explains:&I knew that if we focused on infusing biocompatible nanoparticles withCyclosporine A, the drug in the eye drops, and make them stick to the eyeballwithout irritation for longer periods of time, it would also save patients timeand reduce the possibility of toxic exposure due to excessive use of eyedrops.&这篇论文的带头作者—滑铁卢大学工程系博士生Shengyaen (Sandy) Liu解释道：“如果我们将研究重点放在将环孢菌素A添加在与生物相适应的纳米材料上，从而作为滴眼剂的药物，进而使他们毫无刺激的长时间粘附于眼球上，这也会节约患者的时间以及降低患者因多次使用滴眼液从而增加的感染风险。”建议译文：这篇论文的第一作者、滑铁卢大学工程系博士生Shengyaen(Sandy) Liu解释说：“如果我们将研究重点放在将环孢菌素A浸泡生物相容纳米颗粒上，作成滴眼液，并使其毫无刺激地长时间粘附眼球， 这也会节约患者的时间并减低患者因过多使用滴眼液致中毒暴露的可能性。”说明：Toxic 有毒的，中毒的原文整句未提“感染”，原译文中的“感染”为误译12.He says, &You can't tell thedifference between these nanoparticle eye drops and water. There's no irritation to theeye.&The team is now working on setting up clinical trials to test the nanoparticleeye drops and foresees them being available in drugstores in the next 5 years.他说：“你根本无法区别纳米滴眼液与普通滴眼液的区别。他们对眼睛毫无刺激。”如今这个团队正致力于这种纳米滴眼液的临床试验，并且预测将出现在药房的专柜。建议译文：他说：“你无法说出纳米滴眼液与水的区别。他们对眼睛毫无刺激。”如今这个团队正安排这种纳米滴眼液的临床试验，并预见5年内将出现在药房。说明：[1] water水,何来“普通滴眼液”？[2]区别……与……的区别，这是什么句型？[3] in the next 5 years
是“5年内”，不是“5年后”[4] ……药房的专柜
“专柜”为随意添加，违背“信达雅”原则的“信”13.The Natural Sciences and EngineeringResearch Council of Canada and 20/20: Ophthalmic Materials Network funded thestudy.In August 2014, Medical News Today reported how another team - inspired bylubricants found in nature - is developing a new material that deliverslong-lasting lubrication. One possible application is to make contact lensesmore comfortable.加拿大自然科学与工程研究委员会以及眼科材料网络资助了这项研究。2014年8月今日医学新闻报道了另一个团队是如何从自然界的润滑油上发现灵感的，这种润滑油有望能逐渐发展成一种新的有持久润滑功能的材料。一个可能的应用就是制造出更加舒适的隐形眼镜。建议译文：……。2014年8月“今日医学新闻”报道了从自然界润滑剂上获得灵感的另一个团队是如何正在研发一种有持久润滑作用的新材料。该材料一个可能的应用就是制造出更加舒适的隐形眼镜。@
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
还是weioncol君翻译的好啊，专业而且读起来浅显易懂，很值得我学习。但有几处有点疑问，望悉心指导。该句中的a solution 本意就是“方法”的意思，而君根据全文译成”泪液“ 。我自我感觉还是译成方法好吧。[img]data:image/base64,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
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
袋鼠0405 edited on
Mark一下，以后详细拜读
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
我翻译了资讯，不知能不能有用，谢谢
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
关于丁香园